Skip to content

IMRN

Immuron Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$1.22
+3.39%
Ask drillr

Next report

Analyst consensus

Next report date
Feb 19, 2027
EPS estimate
-$0.01
Revenue estimate
$3.4M

Latest reported

Last report date
Aug 28, 2026
EPS actual
-$0.17
EPS estimate
-$0.00
Revenue actual
$2.5M
Revenue estimate
$2.7M

Track record

Trailing twelve quarters

EPS beats (12Q)
0
EPS misses (12Q)
4
EPS in line (12Q)
0
Avg surprise (4Q)
-2814.4%
Revenue beats (12Q)
3
Earnings call history
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 28, 2026-$0.00-$0.17Miss -4529.32%$2.5M
Feb 24, 2026-$0.01-$0.20Miss -2586.23%$3.0M
Aug 28, 2025-$0.01-$0.31Miss -2219.50%$2.2M
Feb 28, 2025-$0.01-$0.27Miss -1922.73%$2.5M
Oct 2, 2024-$0.01$1.7M
Aug 29, 2024-$0.57$1.7M
Feb 27, 2024-$0.25$1.6M
Jun 30, 2021-$0.35$94.2K
Jun 30, 2020-$0.22$666.5K
Aug 30, 2019-$0.58$985.1K

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 19, 2027